Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarray for serotyping of Bartonella species.

Cyrille J Bonhomme1, Claude Nappez, Didier Raoult

  • 1Unité des Rickettsies, CNRS UMR 6020, Faculté de Médecine de Marseille, Marseille cedex 05, France. cyrille.bomhomme@medecine.univ-mrs.fr <cyrille.bomhomme@medecine.univ-mrs.fr>

BMC Microbiology
|June 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing a new human pneumococcal standard reference serum, MPRSS-01.

mSphere·2025
Same author

Identification of 2,4-Di-<i>tert</i>-Butylphenol as an Antimicrobial Agent Against <i>Cutibacterium acnes</i> Bacteria from Rwandan Propolis.

Antibiotics (Basel, Switzerland)·2024
Same author

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.

Human vaccines & immunotherapeutics·2024
Same author

Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccination.

Clinical & translational immunology·2022
Same author

Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.

PloS one·2022
Same author

A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.

EClinicalMedicine·2021

A novel microarray effectively serotypes Bartonella bacteria strains, aiding in the identification of subspecies and antibody profiles. This method offers a practical approach for bacterial identification in research and diagnostics.

Area of Science:

  • Microbiology
  • Immunology
  • Biotechnology

Background:

  • Bacteria of the genus Bartonella cause diverse human and animal diseases.
  • Serological typing is crucial for differentiating Bartonella subspecies.

Purpose of the Study:

  • To develop and validate a novel multiple antigenic microarray for Bartonella serotyping.
  • To select and characterize polyclonal and monoclonal antibodies against Bartonella.

Main Methods:

  • Development of a multiple antigenic microarray.
  • Validation using mouse polyclonal antibodies against 29 Bartonella strains.
  • Testing the microarray for serotyping and defining monoclonal antibody profiles.

Main Results:

Related Experiment Videos

  • The microarray correctly identified all tested Bartonella strains with strong positive signals.
  • Screening of monoclonal antibodies against Gro EL protein identified 3 antibody groups with variable affinities.

    • Conclusions:

    • Spotted bacteria microarrays are practical tools for serotyping unidentified Bartonella strains.
    • The method facilitates affinity determination for polyclonal and monoclonal antibodies.
    • This approach is valuable for bacterial identification in research and diagnostic settings.